Lumerax 40 Tablet

Brand Name

Lumerax 40 Tablet

🔹 Composition

Each tablet contains:

• Artemether 40 mg

• Lumefantrine 240 mg

🔹 Manufacturer

Ipca Laboratories Ltd.

🔹 Category

Antimalarial Medicine

📌 Description

Lumerax 40 Tablet is a combination antimalarial medicine containing Artemether (rapid-acting schizonticide) and Lumefantrine (long-acting antimalarial). It is recommended by the WHO for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum, including drug-resistant strains. The dual mechanism provides quick symptom relief and prevents recurrence.

✅ Indications / Uses

Lumerax 40 Tablet is prescribed for:

• Uncomplicated Plasmodium falciparum malaria

• Malaria resistant to chloroquine and other standard therapies

• Mixed malaria infections (as per physician’s advice)

💊 Dosage & Administration

• Children (15–24 kg body weight): Usually 2 tablets twice daily for 3 days (total 6 doses).

• Take with milk or fatty food to improve absorption.

• Always follow physician’s instructions.

• Not for infants below 5 kg or for prophylaxis.

⚠️ Side Effects

Common:

• Headache, dizziness

• Nausea, vomiting, abdominal pain

• Loss of appetite, weakness

Serious (rare):

• QT prolongation (irregular heartbeat)

• Severe allergic reaction (rash, swelling, breathing difficulty)

• Liver or blood-related disturbances

⚠️ Precautions & Warnings

• Not for severe malaria treatment.

• Use cautiously in patients with heart, liver, or kidney disorders.

• Avoid concurrent use with QT-prolonging medicines.

• Use in pregnancy only if clearly prescribed.

• Not recommended in breastfeeding unless advised.

📦 Storage

• Store below 25–30°C, in a dry place.

• Keep away from sunlight and moisture.

• Keep out of children’s reach.

🏷️ Key Highlights

• WHO-recommended Artemisinin Combination Therapy (ACT)

• Fast parasite clearance + long-term relapse prevention

• Effective against chloroquine-resistant P. falciparum

• Child-friendly intermediate strength formulation (40/240 mg)